Tag Archives: Swine Flu

UK: Swine Flu ‘Backlash’ Continues

By Julian Upton | Published: August 11, 2009
Barely two weeks after the pricing and profit margins of Big Pharma’s swine flu vaccines and anti-virals were the subject of the critical spotlight in the UK media, Roche’s Tamiflu (oseltamivir) has come under scrutiny, fuelled by articles in the British Medical Journal (BMJ) and The Lancet Infectious Diseases questioning the drug’s effectiveness in young [...]
Posted in Global, Regulatory, Safety | Also tagged , , , | 2 Comments

Is a Swine Flu Vaccine Backlash on the Cards?

By Julian Upton | Published: July 23, 2009
Image by The Artifex via Flickr The risk of over-production has paid off: world orders for swine vaccines will see billions of dollars in extra revenue for the biggest pharma companies. GlaxoSmithKline, Roche, Sanofi-Aventis, Novartis, and Baxter are all expected to report very healthy first-half earnings as a result of a wealth of government contracts for [...]
Posted in Global, News | Also tagged , , , , , , | 1 Comment

Phony Tamiflu Sites Spike in Wake of Swine Flu

By George Koroneos | Published: May 27, 2009
In the wake of the swine flu craze, at least 55 Web sites have sprung up in the last few weeks selling Tamiflu. That’s according to a new report by data firm MarkMonitor. Two of the pharmacies are certified—one in the US and one in the UK—and six of the pharmacies are actually using the [...]
Posted in Safety | Also tagged , , , , , | 2 Comments